+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

The tag Edrecolomab returned 0 results.

No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.

Edrecolomab is a monoclonal antibody used in the treatment of colorectal cancer. It is a type of oncology drug, which is used to target and destroy cancer cells. Edrecolomab works by binding to a specific antigen found on the surface of colorectal cancer cells, which triggers an immune response that destroys the cancer cells. It is typically used in combination with other chemotherapy drugs to increase the effectiveness of the treatment. Edrecolomab is approved for use in the United States, Europe, and other countries. It is available in both intravenous and subcutaneous forms, and is typically administered in combination with other chemotherapy drugs. The drug has been shown to be effective in treating colorectal cancer, and is generally well-tolerated by patients. Some companies in the Edrecolomab market include Merck, Pfizer, Bristol-Myers Squibb, and Roche. Show Less Read more